Alteratioon in proliferative and endocrine responsiveness of human mammary carcinoma cells by prototypic tumor-suppressing agents
- 1 May 1993
- Vol. 58 (5) , 215-219
- https://doi.org/10.1016/0039-128x(93)90021-e
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cellsSteroids, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in miceCarcinogenesis: Integrative Cancer Research, 1991
- Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cellsBreast Cancer Research and Treatment, 1991
- Suppression of Mouse Mammary Tumorigenesis by Long-Term Tamoxifen TherapyJNCI Journal of the National Cancer Institute, 1991
- In vitro biotransformation of estradiol by explant cultures of murine mammary tissuesBreast Cancer Research and Treatment, 1989
- Biological differences among MCF-7 human breast cancer cell lines from different laboratoriesBreast Cancer Research and Treatment, 1987
- 16?-Hydroxylation of Estradiol: A Possible Risk Marker for Breast CancerAnnals of the New York Academy of Sciences, 1986
- Monohydroxytamoxifen: An antioestrogen with high affinity for the chick oviduct oestrogen receptorBiochemical and Biophysical Research Communications, 1979
- In Vitro Model Systems for the Study of Hormone-Dependent Human Breast CancerNew England Journal of Medicine, 1977